美国公共保险与私人保险儿童神经发育障碍研究
该研究基于2000-2014年医疗补助分析提取数据和2003-2015年IBM MarketScan研究数据库,纳入2070541名公共保险和1309900名私人保险出生即参保儿童,评估神经发育障碍的发病率和诊断时机。至8岁时,23.9%公共保险儿童和11.0%私人保险儿童被诊断至少一种神经发育障碍,男孩和白色人种风险更高,私人保险儿童诊断通常略早。
要点
- 至8岁时,23.9%公共保险儿童和11.0%私人保险儿童被诊断至少一种神经发育障碍。
- 男孩风险高于女孩:公共保险30.7% vs 16.7%,私人保险15.0% vs 6.7%。
- 自闭症谱系障碍和智力障碍儿童中超过70%共病至少一种其他神经发育障碍。
核心结论
- 该研究发现在公共保险和私人保险儿童中,神经发育障碍的发病率较高且共病常见,并且发病率及诊断时机因保险类型和种族与族裔而异。
- 作者认为这些发现是重要的公共卫生问题,并强调需要及时且可及的发展评估和教育服务以帮助减轻这些障碍的负担。
研究设计与样本
- 该研究为基于人群的队列研究,使用2000-2014年医疗补助分析提取数据和2003-2015年IBM MarketScan研究数据库中出生队列的全国数据。
- 纳入2070541名公共保险儿童(1045426名男孩[50.5%])和1309900名私人保险儿童(667607名男孩[51.0%]),均在出生时参保。
- 数据分析时间为2020年5月1日至2021年6月30日。
主要发现
- 至8岁时,23.9%公共保险儿童和11.0%私人保险儿童被诊断一种或多种神经发育障碍(自闭症谱系障碍1.6%和1.3%;注意缺陷多动障碍14.5%和5.8%;学习障碍1.2%和0.6%;言语或语言障碍8.4%和4.5%;发育性协调障碍0.9%和0.7%;智力障碍0.7%和0.1%;行为障碍8.4%和1.5%)。
- 至8岁时至少一种神经发育障碍的发病率:公共保险儿童中男孩30.7% vs 女孩16.7%,私人保险儿童中男孩15.0% vs 女孩6.7%。
- 公共保险儿童中,至8岁时至少一种神经发育障碍的发病率:白色人种儿童30.2% vs 亚裔儿童9.1%,黑色人种儿童23.0%,西班牙裔儿童15.4%,未知种族或族裔儿童22.7%(种族和族裔信息仅公共保险儿童可得)。
- 除注意缺陷多动障碍外,私人保险儿童的诊断倾向于略早确立;种族和族裔与诊断年龄的关联因结局而异。
- 共病神经发育障碍常见,尤其在自闭症谱系障碍和智力障碍儿童中(超过70%有至少一种其他障碍)。
临床怎么用
- 作者认为这些发现是重要的公共卫生问题,并强调需要及时且可及的发展评估和教育服务以帮助减轻这些障碍的负担。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
IMPORTANCE: Neurodevelopmental disorders are associated with poor health and social outcomes. Population-based data on incidence, age at diagnosis, and demographic variations are essential to identify modifiable risk factors and inform the planning of services and interventions. OBJECTIVES: To assess the incidence and timing of diagnosis of neurodevelopmental disorders during childhood in the US and to evaluate differences by population characteristics. DESIGN, SETTING, AND PARTICIPANTS: This population-based cohort study used nationwide data on birth cohorts nested in the 2000-2014 Medicaid Analytic eXtract and the 2003-2015 IBM MarketScan Research Database on 2 070 541 publicly and 1 309 900 privately insured children enrolled at birth. Data were analyzed between May 1, 2020, and June 30, 2021. MAIN OUTCOMES AND MEASURES: Neurodevelopmental disorders, autism spectrum disorders, attention-deficit/hyperactivity disorder, learning disabilities, speech or language disorders, developmental coordination disorders, intellectual disabilities, and behavioral disorders were identified based on validated algorithms. Kaplan-Meier analyses were used to estimate the incidence and timing of diagnosis, stratified by child's sex, birth year, maternal age at delivery, and race and ethnicity. RESULTS: The cohorts comprised 2 070 541 publicly insured children (1 045 426 boys [50.5%]) and 1 309 900 privately insured children (667 607 boys [51.0%]) enrolled at birth. By 8 years of age, 23.9% of publicly insured children and 11.0% of privately insured children received a diagnosis of 1 or more neurodevelopmental disorders (autism spectrum disorder, 1.6% and 1.3%; attention-deficit/hyperactivity disorder, 14.5% and 5.8%; learning disability, 1.2% and 0.6%; speech or language disorder, 8.4% and 4.5%; developmental coordination disorder, 0.9% and 0.7%; intellectual disability, 0.7% and 0.1%; and behavioral disorder, 8.4% and 1.5%). Risks were substantially higher among boys (incidence of ≥1 neurodevelopmental disorder by age 8 years for boys vs girls: 30.7% vs 16.7% among publicly insured children and 15.0% vs 6.7% among privately insured children) and White children (30.2% vs 9.1% among Asian children, 23.0% among Black children, 15.4% among Hispanic children, and 22.7% among children of unknown race or ethnicity; information on race and ethnicity was available only for publicly insured children). The association of maternal age and birth year with incidence of neurodevelopmental disorders varied by outcome. Except for attention-deficit/hyperactivity disorder, the diagnosis tended to be established somewhat earlier for privately insured children. The association of race and ethnicity with age at diagnosis varied by outcome. Co-occurring neurodevelopmental disorders were common, especially among children with autism spectrum disorder and intellectual disability (>70% had ≥1 other disorder). CONCLUSIONS AND RELEVANCE: In this population-based cohort study, a relatively high incidence of and co-occurrence of neurodevelopmental disorders as well as the disparity in incidence and timing of diagnosis by insurance type and race and ethnicity were found. These findings represent important public health concerns and underscore the need for timely and accessible developmental assessments and educational services to help reduce the burden of these disorders.
引用
- Straub L, Bateman BT, Hernandez-Diaz S, et al. Neurodevelopmental Disorders Among Publicly or Privately Insured Children in the United States. JAMA Psychiatry. 2022. PMID: 34985527. doi:10.1001/jamapsychiatry.2021.3815
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。